A sickle cell disease specialist at the Komfo Anokye Teaching Hospital has revealed that a potential cure for the condition exists through gene therapy, but costs as much as $3 million, placing it far beyond the reach of most patients.
Dr. Lawrence Osei Tutu explained that advances in gene therapy can now correct the genetic defect responsible for sickle cell disease, effectively transforming abnormal cells into normal ones.
“The genes are like twins. So you get half from your dad and half from your mom… It is curable but you need $3 million. There is gene therapy now which can correct it from abnormal to normal,” he said.
The disclosure highlights a widening gap between medical innovation and access, as patients in Ghana and other developing countries continue to struggle with the burden of a disease that remains life-threatening and expensive to manage.
Beyond the promise of a potential cure, patients and families say the day-to-day reality remains harsh. Many are forced to deal with frequent hospital visits, rising medical costs and repeated crises that disrupt education, work and family life.
“My son falls sick every two weeks. His crisis is very rampant. It is really tough. The financial implication is troubling,” Boahemaa Sarah, a parent told Citi News.
Medical experts note that sickle cell disease is an inherited genetic condition that affects haemoglobin, the protein responsible for carrying oxygen in red blood cells. When defective, it causes cells to become rigid and sickle-shaped, blocking blood vessels and triggering painful complications.
Despite medical advances, experts say the condition continues to impose significant emotional, social and financial strain on patients and their families.
